You can buy or sell Omeros and other stocks, options, ETFs, and crypto commission-free!
Omeros Corp. operates as a biopharmaceutical company. It engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. Read More It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
52 Week High
52 Week Low
Yahoo FinanceMay 15
Omeros to Present at the UBS Global Healthcare Conference
SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the UBS Global Healthcare Conference in New York next week. The presentation is scheduled for Wednesday, May 22, 2019 at 8:00 a.m. EDT. The presentation will be webcast. The live and archived webcasts can be accessed on the investor relations page of company’s website at www.omeros.com. Scroll to continue with content Ad About Omeros Corporation Ome...
Yahoo FinanceMay 9
Omeros Reports Q1 Loss, Lags Revenue Estimates
Omeros (OMER) delivered earnings and revenue surprises of -11.76% and -4.73%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Yahoo FinanceMay 9
Omeros Corporation Reports First Quarter 2019 Financial Results
SEATTLE--(BUSINESS WIRE)-- – Conference Call Today at 4:30 p.m. ET – Omeros Corporation (OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system and immune-related diseases, including cancers, today announced recent highlights and developments as well as financial results for...
Expected Aug 8, After Hours